The company operates one of the largest outdoor cultivation facilities in Colombia, benefits from below-industry-average production costs, and is in the early stages of an international expansion strategy that has established a robust supply chain and distribution network to support its portfolio of revenue-generating brands. In September 2025, Flora Growth announced a private investment in public equity offering positioning the company to implement a 0G treasury strategy, and upon close of the transaction, the company expects to rebrand as ZeroStack while retaining the FLGC ticker symbol.
Cyborg Score Rationale
Flora Growth operates a diversified cannabis and pharmaceutical distribution network with significant global reach and cost-advantaged cultivation. However, the recent pivot toward cryptocurrency/blockchain treasury strategy (September 2025) introduces uncertainty and mission drift concerns. Ongoing capital raises suggest funding pressures.
Top Insights
Operates three distinct business segments (House of Brands, Commercial & Wholesale, Pharmaceuticals) generating scale and diversification across global markets
Announced a $401M PIPE transaction in September 2025 led by DeFi Dev Corp., Hexstone Capital, and Carlsberg SE Asia with $366M in digital assets and $35M in cash commitments
Acquired Franchise Global Health in December 2022, enabling direct leverage of Colombian-grown cannabis into the German pharmaceutical and medical cannabis distribution network across 28 countries
Market capitalization of $1.62B as of June 2026 with 343 employees